StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$4.52−0.33 (-6.80%)

Close on Nov 17, 2026Market cap $284.05MP/E –Yield –

Cytosorbents price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cytosorbents's price to book ratio was 206.4× on Jul 31, 2026, against 73.1× a year earlier. Over the last 5 years it ranged from 24.9× to 280.7×, with a median of 72.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 2026206.4×+117.4
2025Dec 31, 202589.0×+14.9
2024Dec 31, 202474.1×+22.4
2023Dec 29, 202351.8×+17.2
2022Dec 30, 202234.6×−17.0
2021Dec 31, 202151.6×−34.2
2020Dec 31, 202085.8×−285.0
2019Dec 31, 2019370.7×+116.0
2018Dec 31, 2018254.7×−136.1
2017Dec 29, 2017390.8×−6.7
2016Jul 29, 2016397.5×+97.7
2015Dec 31, 2015299.8×−62.8
2013Jan 31, 2013362.6×−95.1
2012Dec 31, 2012457.6×−34.1
2011Dec 30, 2011491.8×–

More Cytosorbents figures

See a number that looks wrong?